“I am passionate about CART for two reasons. First, we desperately need a cure/prevention for Alzheimer’s disease, and Rotary has the potential to make a difference. Rotarians in your district, and those around the world, each with a small commitment, could eradicate Alzheimer’s disease much like it has done for the eradication of polio. Second, Roger Ackerman the founder of CART. He was the brains, spirit, and passion behind CART. I am so committed to CART because I know that CART, like Roger, has a singular purpose for doing good. There is no other agenda other than making a difference for humanity.”
Dr. Allan Levey
The First CART Grant Recipient
Professor and Chairman of the Department of Neurology at Emory University
Director of the Emory Alzheimer’s Disease Research Center.
In 1999, the first grant of $100,000 was awarded to Dr. Allan Levey with Emory University.
Since then, the CART Fund has provided over $7 million to support cutting edge research to help find a cure for Alzheimer's.
More than 5 million Americans now have Alzheimer's disease. By 2050, nearly 14 million (13.8 million) Americans over age 65 could be living with the disease, unless scientists develop new approaches to prevent or cure it.1
1 Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer's disease in the United States (2010-2050) estimated using the 2010 Census. Neurology. Available at www.neurology.org/content/early/2013/02/06/WNL.0b013e31828726f5.abstract. Published online before print, Feb. 6, 2013.
Total payments in 2018
(in 2018 dollars) for all individuals with Alzheimer’s or other dementias are estimated at $277 billion, according to alz.org.
Alzheimer's disease is an irreversible degeneration of the brain that causes disruptions in memory, cognition, personality, and other functions that eventually lead to death from complete brain failure.